Cargando…
Changes in therapy and survival of metastatic renal cell carcinoma in Estonia
BACKGROUND: Before the era of targeted therapies, cytokines were the main therapy for metastatic renal cell carcinoma (mRCC). Our aim was to analyze the changes in treatments and overall survival (OS) of all mRCC patients in Estonia in relation to the introduction of new medications. METHODS: All pa...
Autores principales: | Jürgens, Hannes, Ojamaa, Kristiina, Pokker, Helis, Innos, Kaire, Padrik, Peeter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068934/ https://www.ncbi.nlm.nih.gov/pubmed/32164576 http://dx.doi.org/10.1186/s12885-020-6685-y |
Ejemplares similares
-
Sex differences in cancer survival in Estonia: a population-based study
por: Innos, Kaire, et al.
Publicado: (2015) -
Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014
por: Ojamaa, Kristiina, et al.
Publicado: (2018) -
Identifying women at risk for delayed presentation of breast cancer: a cross-sectional study in Estonia
por: Innos, Kaire, et al.
Publicado: (2013) -
Age-specific cancer survival in Estonia: recent trends and data quality
por: Innos, Kaire, et al.
Publicado: (2015) -
Incidence and Survival for Head and Neck Cancers in Estonia, 1996–2016: A Population-Based Study
por: Kase, Sandra, et al.
Publicado: (2021)